4 unknown. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Unknown 4 |
Follow Endostar: new trials by email Literature Review of Endostar trials Research Report on Endostar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma recombinant human endostatin, pemetrexed plus cisplatin or carboplatin - Adenocarcinoma of Lung | Phase 4 | Unknown | Anhui Provincial Hospital | 100 | 2016-06-01 | 2016-06-21 |
| Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous Carcinoma Endostar, Docetaxel, Cisplatin - Advanced Lung Squamous Carcinoma | Phase 4 | Unknown | Nanjing NingQi Medicine Science and Technology Co., Ltd. | 400 | 2015-03-01 | 2015-07-31 |
| Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research Endostar, Changchun marina, cisplatin - Non-small Cell Lung Cancer | Phase 4 | Unknown | Nanjing NingQi Medicine Science and Technology Co., Ltd. | 400 | 2015-02-01 | 2015-08-04 |
| A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC) Endostar, Gemcitabine-Cisplatin chemotherapy - Non-small Cell Lung Cancer (NSCLC) | Phase 4 | Unknown | Simcere Pharmaceutical Co., Ltd | 120 | 2009-09-01 | 2009-12-09 |
Carcinoma, Non-Small-Cell Lung (2) · Adenocarcinoma of Lung (1)
Nanjing NingQi Medicine Science and Technology Co., Ltd. (2) · Anhui Provincial Hospital (1) · Simcere Pharmaceutical Co., Ltd (1)
China (4)
Lejie Cao, professor (1) · Yiping Zhang, Dr. (1)